Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment
Juan Marcos González, F. Reed Johnson, Helen McAteer, et al.
British Journal of Dermatology (2016) Vol. 176, Iss. 3, pp. 777-785
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Discrete Choice Experiments in Health Economics: Past, Present and Future
Vikas Soekhai, Esther W. de Bekker‐Grob, Alan R. Ellis, et al.
PharmacoEconomics (2018) Vol. 37, Iss. 2, pp. 201-226
Open Access | Times Cited: 598
Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review
Vikas Soekhai, Chiara Whichello, Bennett Levitan, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 7, pp. 1324-1331
Open Access | Times Cited: 131
Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments
Ellen Janssen, Brett Hauber, John F. P. Bridges
Value in Health (2017) Vol. 21, Iss. 1, pp. 59-68
Open Access | Times Cited: 62
<p>Patient and physician preferences for attributes of biologic medications for severe asthma</p>
Heather L. Gelhorn, Zaneta Balantac, Christopher S. Ambrose, et al.
Patient Preference and Adherence (2019) Vol. Volume 13, pp. 1253-1268
Open Access | Times Cited: 47
Prescribing antibiotics: Factors driving decision-making in general practice. A discrete choice experiment
Rikke Vognbjerg Sydenham, Dorte Ejg Jarbøl, Malene Plejdrup Hansen, et al.
Social Science & Medicine (2022) Vol. 305, pp. 115033-115033
Open Access | Times Cited: 22
Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis
Matthew Alcusky, Seina Lee, Gordon Lau, et al.
Dermatology and Therapy (2017) Vol. 7, Iss. 4, pp. 463-483
Open Access | Times Cited: 38
Patient-physician discrepancy in the perception of immune-mediated inflammatory diseases: rheumatoid arthritis, psoriatic arthritis and psoriasis. A qualitative systematic review of the literature
José Antonio Sacristán, Tatiana Dilla, Silvia Díaz‐Cerezo, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0234705-e0234705
Open Access | Times Cited: 30
The importance of understanding patient and physician preferences for psoriasis treatment characteristics: a systematic review of discrete-choice experiments
Noem Sain, D. Willems, M. Charokopou, et al.
Current Medical Research and Opinion (2020) Vol. 36, Iss. 8, pp. 1257-1275
Open Access | Times Cited: 24
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey
April W. Armstrong, Sayeli Jayade, Sanika Rege, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 2, pp. 421-439
Open Access | Times Cited: 3
Patients’ and Physicians’ Preferences for Systemic Psoriasis Treatments: A Nationwide Comparative Discrete Choice Experiment (PsoCompare)
Marthe‐Lisa Schaarschmidt, Raphael M. Herr, M. Gutknecht, et al.
Acta Dermato Venereologica (2017) Vol. 98, Iss. 2, pp. 200-205
Open Access | Times Cited: 28
Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan
Timothy Bolt, Hisanori Kobayashi, Jörg Mahlich
PharmacoEconomics - Open (2018) Vol. 3, Iss. 2, pp. 255-264
Open Access | Times Cited: 24
Modeling Heterogeneity in Patients’ Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches
Marco Boeri, Daniel Saure, Alexander Schacht, et al.
PharmacoEconomics (2020) Vol. 38, Iss. 6, pp. 593-606
Closed Access | Times Cited: 23
Identification of factors that may influence the selection of first‐line biological therapy for people with psoriasis: a prospective, multicentre cohort study
Niall Davison, Richard B. Warren, K.J. Mason, et al.
British Journal of Dermatology (2017) Vol. 177, Iss. 3, pp. 828-836
Open Access | Times Cited: 20
Evaluating Risk Tolerance from a Systematic Review of Preferences: The Case of Patients with Psoriasis
Juan Marcos González
Patient (2018) Vol. 11, Iss. 3, pp. 285-300
Closed Access | Times Cited: 19
What is clearance worth? Patients’ stated risk tolerance for psoriasis treatments
Angelyn Fairchild, Shelby D. Reed, F. Reed Johnson, et al.
Journal of Dermatological Treatment (2017) Vol. 28, Iss. 8, pp. 709-715
Closed Access | Times Cited: 17
Opening the ‘Black Box’: An Overview of Methods to Investigate the Decision-Making Process in Choice-Based Surveys
Dan Rigby, Caroline Vass, Katherine Payne
Patient (2019) Vol. 13, Iss. 1, pp. 31-41
Closed Access | Times Cited: 16
Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque Psoriasis
Leila G. Lackey, Xinyi Ng, Jorien Veldwijk, et al.
Value in Health (2023) Vol. 26, Iss. 4, pp. 519-527
Open Access | Times Cited: 4
Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany
Steven R. Feldman, Christine Poulos, I. Gilloteau, et al.
Journal of Dermatological Treatment (2021) Vol. 33, Iss. 3, pp. 1511-1520
Open Access | Times Cited: 8
Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council
Bruce Strober, P.C.M. van de Kerkhof, Kristina Callis Duffin, et al.
American Journal of Clinical Dermatology (2019) Vol. 20, Iss. 5, pp. 699-709
Open Access | Times Cited: 7
The Impact of the Risk Functional Form Assumptions on Maximum Acceptable Risk Measures
Juan Marcos González, Marco Boeri
Patient (2021) Vol. 14, Iss. 6, pp. 827-836
Open Access | Times Cited: 7
Impact of clinical and demographic characteristics on patient preferences for psoriasis treatment features: Results from a discrete-choice experiment in a multicountry study
Marco Boeri, Daniel Saure, Christopher Schuster, et al.
Journal of Dermatological Treatment (2021) Vol. 33, Iss. 3, pp. 1598-1605
Open Access | Times Cited: 5
Measuring the importance of health domains in psoriasis &ndash; discrete choice experiment versus rating scales
M. Gutknecht, Marthe‐Lisa Schaarschmidt, Marion Danner, et al.
Patient Preference and Adherence (2018) Vol. Volume 12, pp. 363-373
Open Access | Times Cited: 3
Identification of unmet care needs, treatment preferences and health economic implications to optimize disease management outcomes in the field of chronic inflammatory skin diseases
D. Willems
(2024)
Open Access
Advancing paediatric psoriasis treatment options for children
Megha M. Tollefson, Dawn H. Siegel
British Journal of Dermatology (2017) Vol. 177, Iss. 6, pp. 1470-1471
Open Access | Times Cited: 2
Patient Preferences throughout the Medical Product Lifecycle
Chiara Whichello
(2020)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top